Transparency, a harm reduction organization specializing in at-home drug testing kits, has announced its official launch as the parent organization of the Bunk Police.
The growing opioid crisis in the US has been exacerbated by various systems and biases, preventing individuals from accessing critical treatments like methadone and buprenorphine.
Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.
Insys announces that it will file for Chapter 11 bankruptcy following the settlement of a legal case regarding its sales tactics for its opioid-based pain killer.
Acino has agreed to sell its transdermal delivery patch business Luye Pharma Group in a deal that will include its manufacturing site in Miesbach, Germany.
The search for more convenient diabetes treatments continues, with Altea Therapeutics reaching a $46m agreement with Eli Lilly and Amylin to develop a transdermal patch administering Byetta.
Janssen-Cilag’s quality control unit has found a defect in certain batches of its Ionsys (fentanyl hydrochloride) management system that could lead to a potentially life-threatening overdose.
US FDA approval for Teva’s transdermal fentanyl patch ushers the Israeli generics giant into the potentially lucrative but often problematic chronic pain therapy sector.
A new avenue of inquiry has been opened in the investigation into the US Food and Drug Administration’s (FDA) ability and commitment to protect the nation’s citizens from unsafe drugs.
Cambrex Corp, the US-based manufacturer of small-molecule active
pharmaceutical ingredients (APIs) and advanced intermediates for
the drug industry, has announced that one of its customers is
recalling a product for which Cambrex...
A novel buccal patch formulation of the opioid painkiller fentanyl
is on track to be filed for approval in the third quarter of this
year, following encouraging efficacy data from a Phase III trial.
An oral adhesive disc inserted in the cheek could provide a
breakthrough for pain sufferers as the technology does not require
removal upon completion of the drug delivery, having been designed
to disintegrate in the mouth leaving...
